Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of Raute Corporation's Annual General Meeting

RAUTE CORPORATION STOCK EXCHANGE RELEASE 9 MARCH 2023 AT 10:10 EETNOTICE OF RAUTE CORPORATION’S ANNUAL GENERAL MEETING Raute Corporation’s shareholders are invited to attend the company’s Annual General Meeting, which will be held on Thursday, March 30, 2023, at 6:00 p.m. at Sibelius Hall, Ankkurikatu 7, Lahti, Finland. The reception of the registered participants will begin at 5:00 p.m. Shareholders who have registered for the Annual General Meeting can follow the Annual General Meeting online. Instructions for watching the online stream are available on the company’s website at

Caverion delivered cleanroom space to Nexperia in Germany

Caverion Corporation Press release 9 March 2023 at 10.00 a.m. EETCaverion delivered cleanroom space to Nexperia in Germany Nexperia is a global electronics company headquartered in the Netherlands. With increasing digitalisation, the demand for semiconductors has grown strongly - and with it the need for cleanroom space. With more than 1,600 employees, Nexperia in Hamburg produces annually more than 100 billion components, which are needed in every electronic system worldwide. Caverion's know-how helps to keep Nexperia's production up to the latest standards. Caverion has

ExpreS2ion announces formation of Infectious Diseases Scientific Advisory Board

Hørsholm, Denmark, March 9, 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") today announces the establishment of an Infectious Diseases Scientific Advisory Board (ISAB). The four initial members of the ExpreS2ion ISAB bring a depth of knowledge in infectious diseases, clinical trials and preventive vaccines, and will contribute to the development of ExpreS2ion’s proprietary pipeline efforts in the infectious diseases field. The ISAB will serve as advisors and participants in key opinion leader events for the scientific community and investors.

Recipharm’s Arranta Bio expands RNA process development capacity by 50 per cent to meet increased customer demand

Arranta Bio, a Recipharm company and leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, has announced that it has doubled capacity at its Watertown, MA facility for process development services supporting RNA therapeutics. This major development comes less than a year after the acquisition of Arranta Bio by Recipharm, demonstrating Recipharm’s continued focus on the advanced therapeutics market. The expansion includes the fit out of approximately 2,000 ft[2] of state-of-the-art laboratory space with flexible, modular small scale and

Volvo Car AB (publ.) publishes Annual and Sustainability Report 2022

Volvo Cars publishes its Annual and Sustainability Report for 2022 on the Investors website. The report can be found here . In addition to the events and financials of 2022, the Annual and Sustainability Report focuses on the strategic priorities and mid-decade ambitions. Sustainability reporting is integrated in the Annual and Sustainability Report and has been prepared in accordance with Global Reporting Initiative (GRI). Volvo Cars reported an all-time high revenue for the full year 2022. Sales of Volvo’s

Zalaris renews and expands agreement with global top 100 sustainable company to include Hungarian payroll services

Zalaris, the provider of payroll and HR solutions that simplify work life and support creating sustainable businesses, today announced the signing of a six-year renewal of Zalaris PeopleHub to deliver payroll and transactional HR services to one of the top 100 most sustainable global companies of 2023. The agreement expands the eight-year relationship to also cover the company's 3,000+ employees in Hungary.The customer had signed the first agreement with Zalaris in 2015 for Nordic payroll services. Today, the renewal of the payroll Business Process Outsourcing (BPO) agreement with Zalaris,

BioStock: Saniona sees potential for value-creating milestones

After a 2022 with both ups and downs, Saniona is fully focused on pipeline development and partnership discussions. BioStock contacted CEO Thomas Feldthus to learn more about the partnership ambitions for 2023.Read the interview with Thomas Feltdhus at biostock.se: https://www.biostock.se/en/2023/03/saniona-sees-potential-for-value-creating-milestones/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Correction: Raute plans directed share issue, rights issue and junior loan to support targeted growth and strengthening of capital structure and proposes combination of share classes

RAUTE CORPORATION INSIDE INFORMATION 9 March 2023 at 9:50 EET   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   CORRECTION TO RAUTE CORPORATION'S INSIDE INFORMATION RELEASE PUBLISHED ON 9 March 2023 at 8:55 EET.The attachment mentioned in the release, Fairness opinion by Evli Plc, 9 March 2023, was missing from the release. The Fairness opion is now attached to this release, no other

New more sensitive diagnostics protect transplanted kidney

World Kidney Day 2023  With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier, and proper treatment introduced to protect the kidney. Studies show that the level of concentration of donor derived cell free DNA (dd-cfDNA) in blood in the patient may act as an early marker for rejection, following damage to the transplanted kidney. The goal of new more sensitive diagnostics is to increase the survival of the new organ and reduce the need for new transplantation.Kidney transplantation is the best treatment for patients with severe chronic kidney

Himalaya Shipping Ltd. (HSHIP) – Delivery of Mount Ita and commencement of charter

Hamilton, Bermuda, 9 March 2023, Himalaya Shipping is pleased to announce that it has successfully taken delivery of the second of the twelve 210,000 dwt Newcastlemax newbuildings the Company has on order from New Times Shipyard. The vessel (“Mount Ita”) will commence a 32 – 38 month time charter plus option for 11- 13 months and will earn an index-linked rate, reflecting a significant premium to a standard Capesize vessel. The time charters also include a profit sharing of any economic benefit derived from operating the vessel´s scrubber or running on LNG, as well as certain rights

Epiroc accelerates the transformation as its autonomous drills reach milestone

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, continues to accelerate the transformation of the mining industry toward lower emissions, strengthened safety, and higher productivity. Epiroc’s autonomous drill rigs have now achieved another milestone: they have successfully drilled the equivalent length of more than one round around the world.Epiroc’s drill rigs, used by mining and construction customers across the world, are increasingly operated autonomously. The company’s Pit Viper surface drill rigs have now

Akobo Minerals announces results for the fourth quarter of 2022

OSLO, 09 March 2023: Akobo Minerals AB (publ) (ticker: AKOBO), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today reported its fourth quarter 2022 results. As the company is still in the project development phase prior to production start-up, there was no income during the fourth quarter of the year. The net loss for the quarter was SEK 34.2 million. The company has a loan of USD 8.5 million (repayable as 5,000 ounces of gold) and a cash position of SEK 56.3 million.   KEY COMPANY HIGHLIGHTS · A 'de-risked' project · Significant cash flow

French DIY chain selects Pricer’s solution with a framework agreement value of up to 90 MSEK

A leading French DIY chain has selected Pricer for supply and installation of Pricer’s solution for in-store communication and automation based on electronic shelf labels (ESL), the cloud-based platform Pricer Plaza and support services to their more than 100 stores in France.Installation is planned to start at the end of Q2 2023 and is expected to be completed before the end of the year. The value of the framework agreement is up to 90 MSEK, which does not include the subscription fees of Pricer Plaza or support services. The solution that will be installed in all stores in France is

SBTi approves SKF’s near- and long-term science-based emissions reduction targets

SKF has received validation of its Scope 1, 2 and 3 emissions reduction targets from the Science Based Target initiative (SBTi).Gothenburg, 9 March 2023: The SBTi has verified SKF’s net-zero target by 2050, validating both SKF’s near and long-term science-based emissions reduction targets. As the global body enabling companies and financial institutions to set ambitious emissions reductions targets in line with the latest climate science, SBTi validation means that SKF’s targets comply with their criteria and that targets are in line with both climate science and the goals of the Paris

HusCompagniet generates more than DKK 4.3 billion in revenue for 2022 achieving the second-best EBITDA (bsi) in the Groups history and maintained margins at satisfying levels in a weak market

Company announcement 4/2023HusCompagniet delivered more than 2,000 houses for the first time in the Groups history with 2,003 houses delivered in 2022 corresponding to 9% growth over 2021. Reported revenue was DKK 4,330 million for 2022 up 0.3% from the revenue of 2021. The increase was mainly due to an increase in number of houses delivered. The organic growth was -1% as the acquisition of the factory in Esbjerg contributed with revenue DKK 45 million in 2022. EBITDA before special items decreased by 13% to DKK 348 million corresponding to a margin of 8.0%. The rapid shift in market

AI opens up opportunities in healthcare

Artificial intelligence, AI, is a growing field that is expected to have great importance in healthcare and the life science sector. Already today, several AI systems facilitate for both patients and healthcare professionals, as well as save lives through better diagnostics and treatment. AI can also be used in the administration and development of new drugs. As research advances rapidly, more application areas will be added. BioStock lists a number of companies that are active in the AI field.Read the full article at biostock.se: https://www.biostock.se/en/2023/03/ai-opens-up-

2,720 new signs for better waste management

In order to facilitate and improve the waste management in Wallenstam’s 204 properties, new signs are now being put up in all environmental rooms. The signs, which clearly refer to different types of containers for waste and recycling, are based on Swedish Waste Management’s signage system. The ambition, together with the tenants, is to contribute to greater recycling and increased opportunities to achieve a circular economy.In recent years, Wallenstam has worked actively to reduce the properties’ residual waste and improve the opportunities for sorting at source. The goal has been a

AFRY supports the Asian Development Bank in the largest wind power plant in Southeast Asia and first-ever wind project in Laos

AFRY provides Lender’s Technical Advisory services for a flagship large-scale wind farm in Laos that will provide renewable energy to Vietnam.The Monsoon Wind Power project is a 600MW onshore wind farm that will be located in the Sekong and Attapeu provinces in Southern Laos and is expected to export renewable energy to neighbouring Vietnam. With its 133 wind turbines, it will become the largest wind farm in Southeast Asia and the first-ever wind energy project in Laos. The wind farm is owned by Monsoon Wind Power Company Limited (Monsoon) and sponsored by a group of developers led by

Aiforia Technologies Plc Publishes its Board of Directors’ Report and Financial Statements for 2022

Aiforia Technologies Plc, Company release, 9 March 2023 at 09:00 a.m. EET. Aiforia Technologies Plc’s Board of Directors’ Report and Financial Statements for 2022 have been publishedThe Financial Statements consist of the consolidated as well as the parent company’s financial statements and auditor’s report. The Board of Director’s Report and Financial Statements can be found attached to this release and are also available on the company’s website at https://investors.aiforia.com/reports-materials.  Aiforia Technologies PlcBoard of Directors  Further inquiries  Veli-Matti

Imfinzi improved EFS in resectable lung cancer

9 March 2023 07:00 GMT Imfinzi significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer  Results showed that Imfinzi-based treatment before and after surgery significantly increased the time patients live without recurrence or progression events Positive high-level results from a planned interim analysis of the AEGEAN Phase III, placebo- controlled trial showed that treatment with AstraZeneca's Imfinzi (durvalumab) in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after

Moberg Pharma regains full rights to MOB-015 in Japan

STOCKHOLM, March 9[th], 2023, Moberg Pharma AB (OMX: MOB) today announces that Taisho Pharmaceutical Co., Ltd and Moberg Pharma terminate the license agreement for development, registration and commercialization of MOB-015 in Japan. Moberg Pharma regains full rights to the product in Japan and retains milestone revenues paid by Taisho.Taisho has conducted an extensive review on its R&D pipeline and decided to stop the development on MOB-015 due to strategic reasons. Therefore, Moberg Pharma now regains the full rights for MOB-015 in Japan. For additional information, please contact:

iLOQ continues its successful partnership with Kimi Räikkönen

Digital access management pioneer – iLOQ – has announced that it will continue its partnership with the former Formula 1 world champion and current NASCAR driver, Kimi Räikkönen. As official Brand Ambassador, Kimi Räikkönen has been a highly visible presence on iLOQ’s digital channels and at customer and partner events around the world since 2019. The successful partnership is set to continue throughout 2023. “2023 is a big year for iLOQ. We are celebrating our 20th anniversary, putting ourselves firmly on the map in North America and expanding into Southeast Asia. Kimi has

Herantis Pharma to participate in Bio-Europe Spring and AD/PD 2023

Herantis Pharma Plc, Press Release, 9 March 2023 at 09:00 A.M. EET Herantis Pharma Plc (“Herantis”), developing disease-modifying therapies for Parkinson’s disease, today announced participation in the following conferences: Bio-Europe Spring Location: Basel, Switzerland Dates: March 20[th] – 22[nd], 2023 Attendees: CEO Antti Vuolanto, DSc and CSO Dr. Henri Huttunen, PhD AD/PD 2023: International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders Location: Gothenburg, Sweden Dates: March 28[th] – April 1[th], 2023 1. Poster

Exel Composites’ Annual Financial Report 2022 published

EXEL COMPOSITES PLC      ANNUAL FINANCIAL REPORT       9 March 2023 at 09:00 EETExel Composites’ Annual Financial Report, Remuneration Report and Corporate Governance Statement for 2022 have been published today. The Annual Financial Report includes the Board of Directors’ Report, the review by the President and CEO, the consolidated financial statements, the financial statements of the parent company and the auditor’s report. Exel Composites publishes the financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements. The format of the report

There are no items matching the current filter
There are no more items matching the current filter
Back to top